Case Control Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Jun 21, 2016; 22(23): 5384-5392
Published online Jun 21, 2016. doi: 10.3748/wjg.v22.i23.5384
Figure 1
Figure 1 Survival analysis in the sorafenib group and control group. A: Disease-free survival; B: Cumulative survival. DFS: Disease-free survival; OS: Overall survival.